An open-label, randomized phase III trial has been established to compare the efficacy and safety profile of tegafur and uracil (UFT) plus leucovorin with fluorouracil (5-FU) plus leucovorin as first-line chemotherapy for
James Carmichael, BSc, MBChB, MD, FRCP
Advertisement
Articles by James Carmichael, BSc, MBChB, MD, FRCP
Advertisement
Latest Updated Articles
- UFT Plus Leucovorin vs 5-FU Plus Leucovorin for Metastatic Colorectal Cancer
Published: September 2nd 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Issues CRL for Dasatinib in CML/ALL
2
Why is Radiotherapy Not More Accessible as a Cancer Treatment?
3
Raludotatug Deruxtecan Shows Promise in Platinum-Resistant Ovarian Cancer
4
Patient With RRMM, Cytopenias, COPD, and Progressive Bone Disease
5
